HTT and Huntington disease: Importantly, our evidence may support the development of therapeutic strategies already proposed (Tabrizi et al, 2019) such as targeting the pathological processing of HTT mRNA or the HTT exon 1-intron 1 junction to lower HTT1a in HD mutation carriers.